These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 30516432)

  • 1. Antibodies to watch in 2019.
    Kaplon H; Reichert JM
    MAbs; 2019; 11(2):219-238. PubMed ID: 30516432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to watch in 2018.
    Kaplon H; Reichert JM
    MAbs; 2018; 10(2):183-203. PubMed ID: 29300693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to watch in 2020.
    Kaplon H; Muralidharan M; Schneider Z; Reichert JM
    MAbs; 2020; 12(1):1703531. PubMed ID: 31847708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to watch in 2017.
    Reichert JM
    MAbs; 2017; 9(2):167-181. PubMed ID: 27960628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to watch in 2022.
    Kaplon H; Chenoweth A; Crescioli S; Reichert JM
    MAbs; 2022; 14(1):2014296. PubMed ID: 35030985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to watch in 2023.
    Kaplon H; Crescioli S; Chenoweth A; Visweswaraiah J; Reichert JM
    MAbs; 2023; 15(1):2153410. PubMed ID: 36472472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to watch in 2015.
    Reichert JM
    MAbs; 2015; 7(1):1-8. PubMed ID: 25484055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to watch in 2021.
    Kaplon H; Reichert JM
    MAbs; 2021; 13(1):1860476. PubMed ID: 33459118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to watch in 2024.
    Crescioli S; Kaplon H; Chenoweth A; Wang L; Visweswaraiah J; Reichert JM
    MAbs; 2024; 16(1):2297450. PubMed ID: 38178784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to watch in 2016.
    Reichert JM
    MAbs; 2016; 8(2):197-204. PubMed ID: 26651519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments.
    Nagayama A; Ellisen LW; Chabner B; Bardia A
    Target Oncol; 2017 Dec; 12(6):719-739. PubMed ID: 29116596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to watch in 2014: mid-year update.
    Reichert JM
    MAbs; 2014; 6(4):799-802. PubMed ID: 24846335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to watch in 2014.
    Reichert JM
    MAbs; 2014 Jan; 6(1):5-14. PubMed ID: 24284914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to watch in 2013: Mid-year update.
    Reichert JM
    MAbs; 2013; 5(4):513-7. PubMed ID: 23727858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to watch in 2010.
    Reichert JM
    MAbs; 2010; 2(1):84-100. PubMed ID: 20065640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
    Beck A; Wurch T; Reichert JM
    MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13.
    Drugs R D; 2006; 7(6):379-83. PubMed ID: 17073521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-based therapeutics to watch in 2011.
    Reichert JM
    MAbs; 2011; 3(1):76-99. PubMed ID: 21051951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.